Nanocarry Therapeutics
PrivateLast Round
Grant
Jan 1, 2024
Total Funding Raised
$1M
Company Overview
Nanocarry Therapeutics operates in Healthcare & Life Sciences and is based in Ness Ziona. Its latest recorded funding round was a Grant round in January 2024.
Nanocarry Therapeutics is a biopharmaceutical company developing a nanoparticle delivery platform to transport therapeutics across the blood-brain barrier for oncology and central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanocarry Therapeutics Comparables
Compare Nanocarry Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gate2Brain | 84% | |
| B3 Therapeutics | 81% | |
| Ossianix | 78% |
For institutional investors. Book with your work email.
Nanocarry Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2024 | ||||
| Pre Seed | Oct 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanocarry Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Pre Seed |
| Unbox Ventures | Pre Seed |
| Israel Innovation Authority | Grant, Pre Seed |
| Sapir Venture Partners | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2025
Grew 38% QoQ from 8 to 11 employees.
- Mar 21, 2025
Grew 57% QoQ from 7 to 11 employees.
For institutional investors. Book with your work email.
Nanocarry Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanocarry Therapeutics's valuation, stock price, and market status.
Is Nanocarry Therapeutics a public or private company?
Nanocarry Therapeutics is a private company.
What is the current stock price of Nanocarry Therapeutics?
Nanocarry Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nanocarry Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanocarry Therapeutics worth (valuation)?
Valuation information for Nanocarry Therapeutics is not publicly available.
Can I buy Nanocarry Therapeutics stock?
Nanocarry Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanocarry Therapeutics's last funding round?
Nanocarry Therapeutics's most recent funding round was Grant on January 1, 2024.
Who are the main investors in Nanocarry Therapeutics?
Key investors in Nanocarry Therapeutics include NFX.
Will Nanocarry Therapeutics IPO soon?
No public IPO plans have been announced for Nanocarry Therapeutics.
How can I track Nanocarry Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nanocarry Therapeutics's shares on secondary markets.